Terms: = Endocrine gland cancer AND KCNJ5, ENSG00000120457, 3762, P48544, KIR3_4, KATP1, GIRK4 AND Clinical Outcome
3 results:
1. Pathogenesis of Primary Aldosteronism: Impact on clinical outcome.
Santana LS; Guimaraes AG; Almeida MQ
Front Endocrinol (Lausanne); 2022; 13():927669. PubMed ID: 35813615
[TBL] [Abstract] [Full Text] [Related]
2. In situ metabolomics of aldosterone-producing adenomas.
Murakami M; Rhayem Y; Kunzke T; Sun N; Feuchtinger A; Ludwig P; Strom TM; Gomez-Sanchez C; Knösel T; Kirchner T; Williams TA; Reincke M; Walch AK; Beuschlein F
JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484828
[TBL] [Abstract] [Full Text] [Related]
3. Mutations in kcnj5 determines presentation and likelihood of cure in primary hyperaldosteronism.
Ip JC; Pang TC; Pon CK; Zhao JT; Sywak MS; Gill AJ; Soon PS; Sidhu SB
ANZ J Surg; 2015 Apr; 85(4):279-83. PubMed ID: 24274318
[TBL] [Abstract] [Full Text] [Related]
